News

Telomir Pharmaceuticals' 31% Surge and Pre-market Movers

Telomir Pharmaceuticals' 31% Surge and Pre-market Movers

Telomir Pharmaceuticals Sees Significant Pre-market Surge

Shares of Telomir Pharmaceuticals Inc (NASDAQ: TELO) experienced a remarkable increase of 31%, reaching $1.86 in pre-market trading. This boost comes in the wake of encouraging preclinical results regarding their primary compound, Telomir-1.

Promising Preclinical Study Results

The biotechnology firm disclosed these significant findings in an SEC Form 8-K. According to the report, Telomir-1 has successfully reversed abnormal DNA methylation in aggressive prostate cancer models. This outcome is considered a substantial step forward in cancer treatment and may attract considerable investor interest.

Overall Market Reaction

The rise in Telomir Pharmaceuticals' stock reflects broader market trends in biotechnology investment, especially those focused on innovative cancer therapies. As the market continues to show appetite for promising biopharma stocks, Telomir stands out due to its recent advancements.

Other Noteworthy Pre-market Movements

Alongside Telomir, several other stocks also moved significantly in pre-market trading. Here’s a closer look at some upside movers:

Top Gainers

  • Spruce Biosciences Inc (NASDAQ: SPRB) gained 90.9% to $248.89, continuing its upward trajectory after Monday's gains.
  • C3is Inc (NASDAQ: CISS) surged 73.3% to $3.83.
  • Aptevo Therapeutics Inc (NASDAQ: APVO) rose 40.2% to $1.98.
  • Galecto Inc (NASDAQ: GLTO) increased by 37.5% to $5.10.
  • Datavault AI Inc (NASDAQ: DVLT) was up 27.8%, reaching $2.66.
  • Processa Pharmaceuticals Inc (NASDAQ: PCSA) gained 27.5% to $0.36.
  • BTQ Technologies Corp (NASDAQ: BTQ) jumped 25.7% to $11.44.
  • DBV Technologies SA – AD (NASDAQ: DBVT) rose by 12.8% to $14.99.
  • Amkor Technology Inc (NASDAQ: AMKR) saw an increase of 11.2% to $33.99.

Top Losers

  • Society Pass Inc (NASDAQ: SOPA) fell 24.6% to $4.00.
  • Dermata Therapeutics Inc (NASDAQ: DRMA) decreased by 19.1% to $4.35.
  • Aether Holdings Inc (NASDAQ: ATHR) saw a decline of 16.8% to $4.51.
  • Aehr Test Systems (NASDAQ: AEHR) dropped 15.1% to $26.89.
  • SANUWAVE Health Inc (NASDAQ: SNWV) fell 14.4% to $34.99.
  • Lazydays Holdings Inc (NASDAQ: GORV) tumbled 12.3% to $2.57.
  • NOVONIX Ltd (NASDAQ: NVX) slipped 12.3% to $1.57.
  • OneMedNet Corp (NASDAQ: ONMD) decreased by 12.1% to $2.25.
  • Kaixin Holdings (NASDAQ: KXIN) fell 10.2% to $0.64.

This fluctuation in stock prices indicates a dynamic trading environment, often influenced by recent news and market speculation.

Conclusion

In summary, both Telomir Pharmaceuticals and several other stocks have become crucial points of interest in today’s market. Investors are closely watching Telomir Pharmaceuticals and its innovative research efforts. As these companies continue to innovate, keeping an eye on pre-market trends and developments will be essential for informed investment decisions.

Frequently Asked Questions

What caused the rise in Telomir Pharmaceuticals' stock price?

The stock price surged due to positive preclinical study results for its lead compound, Telomir-1, which showed promising effects in cancer models.

What are the notable gains in the pre-market trading session?

Significant gainers included Spruce Biosciences, C3is Inc, and Aptevo Therapeutics, with increases ranging from 40% to over 90%.

How did the broader market react to Telomir's news?

The news triggered a positive reaction to biopharmaceuticals, indicating strong investor interest in innovative cancer treatments.

What are key strategies for investors observing these stocks?

Investors should monitor pre-market activities and developments in clinical trials to make informed decisions on potential investments.

What factors typically influence pre-market trading?

Factors such as news releases, earnings reports, and macroeconomic events significantly impact pre-market stock movements.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Jari Spirits Set to Shake Up U.S. Market After Big Wins

Updated Category News Views 4

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 6

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 6

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 4

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 3

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Sustainability Investments: $17 Trillion Wager Faces Divergence

Updated Category News Views 4

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Continue Reading
High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 4

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 8

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Graft versus Host Disease Market Growth 2024-2034

Updated Category News Views 133

Growth Insights in the Graft versus Host Disease Market The Graft versus Host Disease (GvHD) market is set to experience significant growth in the coming years. This upsurge is primarily due to the rising use of branded therapies like JAKAFI, IMBRUVICA, ORENCIA, and REZUROCK. Predictions suggest a robust Compound Annual Growth Rate (CAGR) of 9.9% during this period,...

Continue Reading
Midland Exploration Completes Successful Private Placement Funding

Updated Category News Views 218

Midland Exploration Achieves Successful Closing of Private Placement Montreal-based Midland Exploration Inc. is thrilled to announce the successful completion of a non-brokered private placement, raising a total of $3,037,811. This financial boost comes from issuing nearly five million common shares categorized as “flow-through shares” at the price of $0.56 per share,...

Continue Reading
Innovative Fire Safety Strategy: SDGE's Goats in Action

Updated Category News Views 503

Innovative Fire Safety Strategy: SDGE's Goats in Action San Diego Gas & Electric (SDGE) is taking an innovative approach to wildfire prevention that combines a time-honored natural method with modern technology. The company recently launched a new social media initiative, complete with an Instagram account, dedicated to showcasing the role of goats in reducing wildfire...

Continue Reading
eHealth, Inc. Grants New Stock Units to Employees Under Nasdaq Rules

Updated Category News Views 98

eHealth, Inc. Issues Inducement Grants for New Employees In recent news, eHealth, Inc. (Nasdaq: EHTH), a prominent player in the health insurance marketplace, has taken a significant step to enhance its workforce by granting inducement stock unit awards. This decision marks a notable move in the company's strategy to attract and retain talented individuals within the...

Continue Reading
Novo Nordisk's New Pricing Strategy Signals Market Adaptation

Updated Category News Views 368

Novo Nordisk Introduces Cost-Effective Solutions Novo Nordisk A/S (NYSE: NVO) has recently made headlines with its innovative pricing strategy aimed at making its popular weight loss medications, Wegovy and Ozempic, more affordable for patients. In an effort to tackle the escalating competition in the obesity treatment market, the company is offering a limited-time...

Continue Reading